On Jun. 26, 2023, Jaguar Health announced that the Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) had joined the Global Initiative for Veterinary Cancer Surveillance – an international network of veterinary cancer registries with a mission to: 1) promote international collaborations in animal cancer surveillance and research; 2) create a consensus on and foster the establishment of standardized methods for animal cancer coding and reporting; 3) provide an inclusive channel to exchange information between veterinary cancer registries.

Jaguar Health’s Take C.H.A.R.G.E. is a first-of-its-kind national canine cancer registry compiling incidence and prevalence data to help guide canine cancer diagnosis and treatment. The registry catalogs key data points to know cancer’s impact by breed, type, age, gender, and location. The Take C.H.A.R.G.E. registry is sponsored by Jaguar Animal Health, and is cosponsored by TogoRun, a global health communications agency.

According to the National Cancer Institute, which is part of the National Institutes of Health, roughly 6 million new cancer diagnoses are made in dogs each year in the US. Dogs respond to cancer treatments in similar ways to humans and, for the most part, dogs receive human chemotherapeutic agents during treatment and suffer the same side effects as humans, such as nausea and diarrhea. The dynamics of treatment care and supportive care are remarkably similar in dogs and humans, with, for example, approximately 40% of dogs having their cancer care interrupted due to treatment-related diarrhea.